SmartCella Holding AB

SmartCella Holding AB is a global biotechnology company dedicated to pioneering the future of targeted therapies through innovative delivery solutions and advanced therapy development. With roots in world-renowned science and research from Karolinska Institutet in Sweden, SmartCella Holding AB is committed to shaping the future of medicine.

Operating in two key business segments, Targeted Delivery and Regenerative Medicines, SmartCella Holding AB combines novel delivery platforms, such as the Extroducer®—an endovascular delivery device enabling direct injection to hard-to-reach organs and tumors—with state-of-the-art development and manufacturing of stem cell-based therapies. The company's primary address is Alfred Nobels Alle 150, Tullinge, Stockholm 14648, SE.

SmartCella Holding AB is driven by an international team of scientists, visionary innovators, and experienced business leaders. The company is dedicated to delivering life-changing treatments to patients worldwide. We encourage the management team at SmartCella Holding AB to create a customized and exclusive company showcase and product listing on our platform to further enhance their market presence.